Last reviewed · How we verify
Teva Branded Pharmaceutical Products R&D LLC — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
1 Phase 3
3 Phase 2
3 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| TV-44749 | TV-44749 | phase 3 | TRPV1 antagonist | TRPV1 (Transient Receptor Potential Vanilloid 1) | Pain Management |
Therapeutic area mix
- Pain Management · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Allergan · 1 shared drug class
- Grünenthal GmbH · 1 shared drug class
- Kissei Pharmaceutical Co., Ltd. · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Teva Branded Pharmaceutical Products R&D LLC:
- Teva Branded Pharmaceutical Products R&D LLC pipeline updates — RSS
- Teva Branded Pharmaceutical Products R&D LLC pipeline updates — Atom
- Teva Branded Pharmaceutical Products R&D LLC pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Teva Branded Pharmaceutical Products R&D LLC — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/teva-branded-pharmaceutical-products-r-d-llc. Accessed 2026-05-17.